Results 81 to 90 of about 2,077 (188)

Non-hormonal therapies for vulvovaginal atrophy: Clinical cases

Гинекология
Menopause is associated with a deficiency of sex hormones, which significantly impacts a woman's physical and psycho-emotional state. In particular, the blood supply to the genitourinary system organs deteriorates, and the synthesis of connective tissue ...
Tatiana B. Motovilova, Liya Z. Sirotina, Oksana I. Trifonova, Irina A. Kruglova, Anastasiya D. Varnavskaya, Kseniia V. Kazakova   +5 more
doaj   +1 more source

Evaluation of cervical screening at treatment of a vulvovaginal atrophy in periand postmenopausal women [PDF]

Гинекология, 2016
Objective. Determination of effective application of vaginal complex estriol 0,2 mg/progesteron 2 mg/Lactobacillus casei rhamnosus 2¥109 at women with a vulvovaginal atrophy in peri-and postmenopausal women with a evaluation of cervical screening ...
T V Klinyshkova, I B Samosudova, O N Mironova   +2 more
doaj  

Safety and Efficacy of an Oxytocin Gel and an Equivalent Gel but Without Hormonal Ingredients (Vagivital® Gel) in Postmenopausal Women with Symptoms of Vulvovaginal Atrophy: A Randomized, Double-Blind Controlled Study

Medical Devices: Evidence and Research, 2020
Aino Fianu Jonasson,1 Marie Bixo,2 Inger Sundström Poromaa,3 Mikael Åstrom4 1Department of Clinical Sciences, Intervention and Technology, Division of Obstetrics and Gynecology, Karolinska Institute, Stockholm, Sweden; 2Department of Clinical ...
Fianu Jonasson A, Bixo M, Sundström Poromaa I, Åstrom M   +3 more
doaj  

An Overview of Vulvovaginal Atrophy‑Related Sexual Dysfunction in Postmenopausal Women

, 2015
Menopause and the climacteric period are associated with adverse risk factors for the development of vulvovaginal atrophyrelated sexual dysfunction.
Agu, PU, Ezenyeaku, CCT, Ikeako, LC, Okeke, TC   +3 more
core  

Efficacy and safety of ultra-low-dose Vagifem (10 mcg)

Patient Preference and Adherence, 2011
Janet A Chollet1,2 1Beth Israel Deaconess Medical Center, Boston, MA, USA; 2Pear Tree Pharmaceuticals, Waltham, MA, USA Abstract: Vulvovaginal atrophy [VVA] is defined as inflammation of the vaginal epithelium due to atrophy secondary to decreased levels
Chollet JA
doaj  

Vulvovaginal atrophy: current methods of diagnosis and treatment

Бюллетень сибирской медицины
Aim. To review modern methods of diagnosis and treatment of vulvovaginal atrophy (VVA), which is one of the manifestations of genitourinary syndrome of menopause in periand postmenopausal women.Materials and methods.
L. F. Zainetdinova, L. F. Telesheva, B. I. Medvedev, V. V. Khakhulina   +3 more
doaj   +1 more source

Vaginal LASER and estrogen comparison in Genitourinary Syndrome of Menopause

Continence
Aim:: This study aims to compare the efficacy of CO2 fractionated laser therapy and topical estrogen treatment in managing Genitourinary Syndrome of Menopause (GSM).
Aytaj Jafarzade, Aydan Biri, Osman Ufuk Ekiz, Tamer Mungan   +3 more
doaj   +1 more source

Dyspareunia in women in preand postmenopausal period [PDF]

Гинекология, 2016
The article presents current views on the multiple pathogenetic mechanisms of development of dyspareunia in women in pre - and postmenopausal women with positions of biopsychosocial approach.
A I Fedorova
doaj  

Vaginal cytokines do not differ between postmenopausal women with and without symptoms of vulvovaginal irritation.

, 2014
OBJECTIVE The aim of this exploratory pilot study was to determine if there are differences in vaginal cytokine levels between postmenopausal women with and without vulvovaginal irritative symptoms (itching, burning, or pain).
Stute, Petra, Kollmann, Zahraa, von Wolff, Michael, Archer, David F, Thurman, Andrea R, Bersinger, Nick A.   +5 more
core   +1 more source

Modulation of vulvovaginal atrophy (VVA) by Gelam honey in bilateral oophorectomized rats. [PDF]

Front Endocrinol (Lausanne), 2023
Ismail NH, Ibrahim SF, Mokhtar MH, Yahaya A, Zulkefli AF, Ankasha SJ, Osman K.   +6 more
europepmc   +1 more source